330 related articles for article (PubMed ID: 23077141)
1. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.
Navab M; Reddy ST; Van Lenten BJ; Buga GM; Hough G; Wagner AC; Fogelman AM
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2553-60. PubMed ID: 23077141
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
3. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
Navab M; Berliner JA; Subbanagounder G; Hama S; Lusis AJ; Castellani LW; Reddy S; Shih D; Shi W; Watson AD; Van Lenten BJ; Vora D; Fogelman AM
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):481-8. PubMed ID: 11304461
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.
Meriwether D; Imaizumi S; Grijalva V; Hough G; Vakili L; Anantharamaiah GM; Farias-Eisner R; Navab M; Fogelman AM; Reddy ST; Shechter I
J Lipid Res; 2011 Oct; 52(10):1795-809. PubMed ID: 21804067
[TBL] [Abstract][Full Text] [Related]
5. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Fonarow GC; Vahabzadeh K; Hama S; Hough G; Kamranpour N; Berliner JA; Lusis AJ; Fogelman AM
J Lipid Res; 2004 Jun; 45(6):993-1007. PubMed ID: 15060092
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
Sherman CB; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
[TBL] [Abstract][Full Text] [Related]
7. The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis.
Wang H; Reddy ST; Fogelman AM
Curr Opin Lipidol; 2022 Oct; 33(5):277-282. PubMed ID: 35979993
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice.
Rivas-Urbina A; Rull A; Aldana-Ramos J; Santos D; Puig N; Farre-Cabrerizo N; Benitez S; Perez A; de Gonzalo-Calvo D; Escola-Gil JC; Julve J; Ordoñez-Llanos J; Sanchez-Quesada JL
Biomolecules; 2020 May; 10(6):. PubMed ID: 32485898
[TBL] [Abstract][Full Text] [Related]
9. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
[TBL] [Abstract][Full Text] [Related]
10. The effect of HDL mimetic peptide 4F on PON1.
Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis.
Leonarduzzi G; Gamba P; Gargiulo S; Biasi F; Poli G
Free Radic Biol Med; 2012 Jan; 52(1):19-34. PubMed ID: 22037514
[TBL] [Abstract][Full Text] [Related]
12. Cationic peptides neutralize Ox-LDL, prevent its uptake by macrophages, and attenuate inflammatory response.
Aluganti Narasimhulu C; Selvarajan K; Brown M; Parthasarathy S
Atherosclerosis; 2014 Sep; 236(1):133-41. PubMed ID: 25036240
[TBL] [Abstract][Full Text] [Related]
13. Oral amphipathic peptides as therapeutic agents.
Reddy ST; Anantharamaiah GM; Navab M; Hama S; Hough G; Grijalva V; Garber DW; Datta G; Fogelman AM
Expert Opin Investig Drugs; 2006 Jan; 15(1):13-21. PubMed ID: 16370930
[TBL] [Abstract][Full Text] [Related]
14. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.
D'Souza W; Stonik JA; Murphy A; Demosky SJ; Sethi AA; Moore XL; Chin-Dusting J; Remaley AT; Sviridov D
Circ Res; 2010 Jul; 107(2):217-27. PubMed ID: 20508181
[TBL] [Abstract][Full Text] [Related]
15. The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR
Zeibig S; Büttcher M; Goebel S; Pauli J; Hunger A; Ungerer M; Gawaz M; Münch G
Cell Physiol Biochem; 2019; 52(4):681-695. PubMed ID: 30921507
[TBL] [Abstract][Full Text] [Related]
16. Oxidized lipids as mediators of coronary heart disease.
Navab M; Hama SY; Reddy ST; Ng CJ; Van Lenten BJ; Laks H; Fogelman AM
Curr Opin Lipidol; 2002 Aug; 13(4):363-72. PubMed ID: 12151851
[TBL] [Abstract][Full Text] [Related]
17. Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides.
Yu R; Yekta B; Vakili L; Gharavi N; Navab M; Marelli D; Ardehali A
Curr Atheroscler Rep; 2008 Apr; 10(2):171-6. PubMed ID: 18417073
[TBL] [Abstract][Full Text] [Related]
18. The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.
Namiri-Kalantari R; Gao F; Chattopadhyay A; Wheeler AA; Navab KD; Farias-Eisner R; Reddy ST
Biofactors; 2015 May; 41(3):153-9. PubMed ID: 26072738
[TBL] [Abstract][Full Text] [Related]
19. The role of high-density lipoprotein in inflammation.
Navab M; Anantharamaiah GM; Fogelman AM
Trends Cardiovasc Med; 2005 May; 15(4):158-61. PubMed ID: 16099381
[TBL] [Abstract][Full Text] [Related]
20. The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties.
Schwendeman A; Sviridov DO; Yuan W; Guo Y; Morin EE; Yuan Y; Stonik J; Freeman L; Ossoli A; Thacker S; Killion S; Pryor M; Chen YE; Turner S; Remaley AT
J Lipid Res; 2015 Sep; 56(9):1727-37. PubMed ID: 26117661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
